Cerity Partners LLC Acquires New Position in Integer Holdings Co. (NYSE:ITGR)

Cerity Partners LLC acquired a new position in shares of Integer Holdings Co. (NYSE:ITGR) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 2,095 shares of the medical equipment provider’s stock, valued at approximately $208,000.

A number of other institutional investors and hedge funds have also bought and sold shares of ITGR. GSA Capital Partners LLP acquired a new position in shares of Integer in the third quarter valued at approximately $816,000. Dark Forest Capital Management LP increased its position in Integer by 69.8% in the 3rd quarter. Dark Forest Capital Management LP now owns 11,984 shares of the medical equipment provider’s stock valued at $940,000 after acquiring an additional 4,926 shares during the period. Legacy Wealth Asset Management LLC acquired a new position in Integer in the 4th quarter valued at approximately $239,000. Trust Point Inc. bought a new position in shares of Integer during the fourth quarter valued at $874,000. Finally, Nomura Holdings Inc. lifted its holdings in shares of Integer by 3.9% during the third quarter. Nomura Holdings Inc. now owns 180,270 shares of the medical equipment provider’s stock worth $14,139,000 after purchasing an additional 6,731 shares during the period. Institutional investors and hedge funds own 99.29% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on ITGR. CL King initiated coverage on Integer in a research report on Thursday, March 14th. They set a “buy” rating and a $137.00 target price for the company. KeyCorp raised their price objective on Integer from $123.00 to $139.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 9th. Bank of America upgraded Integer from a “neutral” rating to a “buy” rating and upped their target price for the company from $105.00 to $135.00 in a report on Monday, April 15th. Finally, Benchmark restated a “buy” rating and set a $130.00 price target on shares of Integer in a report on Friday. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, Integer presently has a consensus rating of “Moderate Buy” and a consensus target price of $120.50.

Integer Trading Up 4.5 %

Shares of ITGR stock opened at $114.54 on Tuesday. Integer Holdings Co. has a fifty-two week low of $69.40 and a fifty-two week high of $123.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.01 and a current ratio of 3.32. The stock has a 50 day simple moving average of $113.41 and a two-hundred day simple moving average of $100.35. The company has a market cap of $3.84 billion, a P/E ratio of 39.63, a PEG ratio of 1.53 and a beta of 1.10.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share for the quarter, beating the consensus estimate of $1.12 by $0.02. Integer had a net margin of 6.01% and a return on equity of 11.25%. The company had revenue of $414.80 million during the quarter, compared to analyst estimates of $412.78 million. During the same quarter in the previous year, the business posted $0.87 EPS. Integer’s revenue for the quarter was up 9.5% compared to the same quarter last year. Research analysts forecast that Integer Holdings Co. will post 5.27 earnings per share for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.